中国飞鹤(06186.HK)溢价1.6%提购原生态牧业(01431.HK)
中国飞鹤(06186.HK)公布,提出要约收购原生态牧业(01431.HK)全数股权,每股作价0.63元,较原生态牧业上周四(3日)收市价0.62元溢价1.6%,原生态牧业於上周五开市前停牌。
相关收购涉及46.9亿股及1.91亿份购股权,涉资分别29.55亿元及6,389.77万元。中国飞鹤表示,收购可进一步加强公司於高端婴幼儿配方奶粉产品市场的领导地位,另外亦可控制整条价值链及进一步提升经营效益。要约人无意於该等要约结束後将原生态牧业私有化,而拟维持该公司於联交所主板之上市地位。
原生态牧业今早起复牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.